tiprankstipranks
Sarepta Therapeutics Inc. (SRPT)
NASDAQ:SRPT
US Market
SRPT
Sarepta Therapeutics
RESEARCH TOOLSreports
Want to see SRPT full AI Analyst Report?

Sarepta Therapeutics (SRPT) Ratios

4,070 Followers

Sarepta Therapeutics Ratios

SRPT's free cash flow for Q1 2026 was $0.84. For the 2026 fiscal year, SRPT's free cash flow was decreased by $ and operating cash flow was $0.49. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.63 2.32 4.20 3.95 4.13
Quick Ratio
 2.62 1.48 3.18 3.45 3.80
Cash Ratio
 0.93 0.73 1.51 0.66 1.56
Solvency Ratio
 0.07 -0.30 0.11 -0.20 -0.24
Operating Cash Flow Ratio
 0.35 -0.19 -0.28 -0.77 -0.53
Short-Term Operating Cash Flow Coverage
 0.00 -18.35 0.00 -4.75 0.00
Net Current Asset Value
$ 636.04M$ 328.86M$ 638.03M$ 174.09M$ -185.56M
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.31 0.34 0.43 0.52
Debt-to-Equity Ratio
 0.69 0.91 0.88 1.63 4.20
Debt-to-Capital Ratio
 0.41 0.48 0.47 0.62 0.81
Long-Term Debt-to-Capital Ratio
 0.36 0.42 0.43 0.57 0.80
Financial Leverage Ratio
 2.11 2.94 2.59 3.80 8.13
Debt Service Coverage Ratio
 3.86 -31.50 15.84 -3.68 -11.43
Interest Coverage Ratio
 -0.97 -67.60 11.86 -12.17 -10.07
Debt to Market Cap
 0.47 0.37 0.10 0.14 0.14
Interest Debt Per Share
 10.27 10.01 14.32 15.36 19.08
Net Debt to EBITDA
 4.71 -0.37 0.76 -2.13 -1.09
Profitability Margins
Gross Profit Margin
62.39%59.90%83.22%87.91%85.00%
EBIT Margin
3.36%-31.50%14.68%-40.06%-68.24%
EBITDA Margin
5.57%-29.48%16.66%-36.49%-63.76%
Operating Profit Margin
-1.88%-29.92%11.47%-21.54%-57.47%
Pretax Profit Margin
1.12%-31.94%13.71%-41.83%-73.95%
Net Profit Margin
2.98%-32.45%12.37%-43.11%-75.40%
Continuous Operations Profit Margin
2.98%-32.45%12.37%-43.11%-75.40%
Net Income Per EBT
265.90%101.59%90.21%103.05%101.96%
EBT Per EBIT
-59.73%106.76%119.58%194.19%128.68%
Return on Assets (ROA)
2.05%-21.30%5.94%-16.42%-22.49%
Return on Equity (ROE)
4.89%-62.55%15.40%-62.37%-182.75%
Return on Capital Employed (ROCE)
-1.53%-29.18%6.75%-10.26%-21.37%
Return on Invested Capital (ROIC)
-1.53%-29.03%6.06%-9.80%-21.24%
Return on Tangible Assets
2.07%-21.48%5.98%-16.57%-22.54%
Earnings Yield
3.64%-31.63%2.03%-6.02%-6.20%
Efficiency Ratios
Receivables Turnover
 3.99 5.52 2.93 2.85 3.57
Payables Turnover
 11.67 3.14 1.49 0.91 1.46
Inventory Turnover
 0.82 0.96 0.43 0.47 0.69
Fixed Asset Turnover
 4.75 4.67 3.89 3.48 3.81
Asset Turnover
 0.69 0.66 0.48 0.38 0.30
Working Capital Turnover Ratio
 1.34 1.16 0.89 0.64 0.46
Cash Conversion Cycle
 505.15 328.60 737.24 511.73 384.18
Days of Sales Outstanding
 91.56 66.12 124.69 128.28 102.34
Days of Inventory Outstanding
 444.86 378.76 857.84 783.83 531.82
Days of Payables Outstanding
 31.27 116.29 245.29 400.38 249.98
Operating Cycle
 536.42 444.89 982.52 912.11 634.15
Cash Flow Ratios
Operating Cash Flow Per Share
 1.67 -1.96 -2.16 -5.42 -3.72
Free Cash Flow Per Share
 1.02 -2.93 -3.71 -6.37 -4.08
CapEx Per Share
 0.65 0.97 1.55 0.95 0.37
Free Cash Flow to Operating Cash Flow
 0.61 1.50 1.71 1.17 1.10
Dividend Paid and CapEx Coverage Ratio
 2.57 -2.02 -1.40 -5.74 -10.09
Capital Expenditure Coverage Ratio
 2.57 -2.02 -1.40 -5.74 -10.09
Operating Cash Flow Coverage Ratio
 0.17 -0.20 -0.15 -0.36 -0.20
Operating Cash Flow to Sales Ratio
 0.08 -0.09 -0.11 -0.40 -0.35
Free Cash Flow Yield
5.97%-13.63%-3.05%-6.60%-3.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.45 -3.16 49.14 -16.62 -16.13
Price-to-Sales (P/S) Ratio
 0.82 1.03 6.08 7.17 12.16
Price-to-Book (P/B) Ratio
 1.19 1.98 7.57 10.37 29.47
Price-to-Free Cash Flow (P/FCF) Ratio
 16.76 -7.33 -32.77 -15.14 -31.73
Price-to-Operating Cash Flow Ratio
 10.19 -10.98 -56.18 -17.78 -34.87
Price-to-Earnings Growth (PEG) Ratio
 0.06 <0.01 -0.34 0.60 -0.29
Price-to-Fair Value
 1.19 1.98 7.57 10.37 29.47
Enterprise Value Multiple
 19.47 -3.85 37.24 -21.77 -20.17
Enterprise Value
 2.37B 2.49B 11.80B 9.88B 12.00B
EV to EBITDA
 19.47 -3.85 37.24 -21.77 -20.17
EV to Sales
 1.08 1.13 6.20 7.95 12.86
EV to Free Cash Flow
 22.10 -8.11 -33.45 -16.79 -33.55
EV to Operating Cash Flow
 13.51 -12.13 -57.34 -19.72 -36.87
Tangible Book Value Per Share
 14.04 10.61 15.79 8.98 4.31
Shareholders’ Equity Per Share
 14.34 10.88 16.07 9.30 4.40
Tax and Other Ratios
Effective Tax Rate
 -1.66 -0.02 0.10 -0.03 -0.02
Revenue Per Share
 20.80 20.98 20.01 13.46 10.66
Net Income Per Share
 0.62 -6.81 2.47 -5.80 -8.03
Tax Burden
 2.66 1.02 0.90 1.03 1.02
Interest Burden
 0.33 1.01 0.93 1.04 1.08
Research & Development to Revenue
 0.41 0.69 0.42 0.71 0.94
SG&A to Revenue
 0.21 0.22 0.29 0.39 0.48
Stock-Based Compensation to Revenue
 0.04 0.06 0.10 0.15 0.25
Income Quality
 2.69 0.29 -0.87 0.93 0.46
Currency in USD